Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma

P Jethwa, Mushal Naqvi, Rowan Hardy, Neil Hotchin, Sally Roberts, Robert Spychal, Chris Tselepis

Research output: Contribution to journalArticle

66 Citations (Scopus)


AIM: To characterise expression of known E-cadherin repressors; Snail, Slug and Twist in the development of esophageal adenocarcinoma. METHODS: E-cadherin, Slug, Snail and Twist mRNA expression in Barrett's metaplasia and esophageal adenocarcinoma specimens was examined by real-time reverse transcription-polymerase chain reaction (RTPCR). Semi-quantitative immunohistochemistry was used to examine cellular localisation and protein levels. The effect of Slug on epithelial mesenchymal transition (EMT) markers was examined by transfection of Slug into an adenocarcinoma line OE33. RESULTS: Cellular localisation of Slug in Barrett's metaplasia was largely cytoplasmic whilst in adenocarcinoma it was nuclear. Semi-quantitative analysis indicated that Slug was more abundant in adenocarcinoma compared to matched Barrett's metaplastic specimens, Snail and Twist were expressed in adenocarcinoma but were cytoplasmic in location and not induced compared to Barrett's mucosa. These observations were supported by mRNA studies where only Slug mRNA was shown to be over-expressed in adenocarcinoma and inversely correlated to E-cadherin expression. Overexpression of Slug in OE33 mediated E-cadherin repression and induced the mesenchymal markers vimentin and fibronectin. CONCLUSION: Progression to adenocarcinoma is associated with increased Slug expression and this may represent a mechanism of E-cadherin silencing. (c) 2008 WJG. All rights reserved.
Original languageEnglish
Pages (from-to)1044-1052
Number of pages9
JournalWorld Journal of Gastroenterology
Issue number7
Publication statusPublished - 1 Jan 2008


  • epithelial-mesenchymal transition
  • oesophagus
  • Barrett's metaplasia
  • cancer
  • Slug


Dive into the research topics of 'Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma'. Together they form a unique fingerprint.

Cite this